Table 1.

Baseline characteristics and GI events during the follow-up.

Number of new NSAID users (total study population)	12,082
Mean age ± s.d.	74.5±6.34
Female gender (%)	61.3
Median number of comedications⋆ (25%, 75% quartiles)	1 (0, 3)
NSAID Rx by rheumatologist at index date (%)	1.3
Median chronic disease score† (25%, 75% quartiles)	1 (0, 4)
Number of patients (%)
All cause death	661 (5.5)
GPA during follow-up	3257 (27.0)
GPA at index date	857 (7.1)
Hospitalizations	217 (1.8)
Diagnostic tests	801 (6.6)

^⋆The number of comedications was the average median of drugs other than NSAIDs, paracetamol (acetaminophen), or GPAs a patient was taking at the index date.

^†The chronic disease score was the sum of the scores (0–5) assigned to drugs the patient took during the year preceding the index date.